Sodium Lowering Vascular Effects Trial
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Tulane University
- Study ID
- NCT05388032
- Status
- Recruiting
Conditions
- Endothelial Dysfunction
- Left Ventricular Dysfunction
- Left Ventricular Hypertrophy
- Vascular Stiffness
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sodium Reduction Intervention — BEHAVIORALThe sodium reduction intervention is a dietician-led behavioral intervention consisting of two phases, first a 3-month intensive intervention phase, followed by a 9-month maintenance phase. The overall goal of the intervention is to reduce sodium intake to \<2,300 mg per day based on the most recent guideline from the National Academies of Medicine. Both phases will include individual and group behavioral modification counseling designed to facilitate a reduction in dietary sodium intake.
Study Details
The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiovascular disease risk in addition to blood pressure and could provide further evidence on sodium reduction for the prevention of cardiovascular disease.
Key Dates
- Start date
- Jan 25, 2023
- Status verified
- Nov 2024
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 256 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: sodium reduction interventionThe sodium reduction intervention is a dietician-led behavioral intervention consisting of two phases, first a 3-month intensive intervention phase, followed by a 9-month maintenance phase. The overall goal of the intervention is to reduce sodium intake to \<2,300 mg per day based on the most recent guideline from the National Academies of Medicine. Both phases will include individual and group behavioral modification counseling designed to facilitate a reduction in dietary sodium intake.
- No Intervention: Usual DietParticipants randomized to the usual diet group will receive standard care from their providers with no study intervention.
Primary Outcome Measure
Change in Left Ventricular Global Longitudinal Strain (LVGLS) from baseline to 12 months [ Time Frame: 12 months ]
Central Contacts
- Marigny Bostock, MA, CHES504-988-4391
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Tulane University Office of Health Research | New Orleans | Louisiana | 70112 |
Find similar trials in New Orleans, LA
By research site
Related Studies
- Diffusion MRI in Heart FailureEARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Charlestown, Massachusetts
- Samples From Human Subjects to Facilitate Basic, Translational and Clinical ResearchRecruiting · National Institutes of Health Clinical Center (CC) · Bethesda, Maryland
- Imaging Histone Deacetylase in the HeartRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Bright Light Exposure in Surgical PatientsRecruiting · University of Colorado, Denver · Denver, Colorado